MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that William M. Caldwell IV, ACT’s Chairman and CEO, will present today at the 18th Annual BioPartnering Europe conference in London at 11:45 a.m. eastern time today. The conference will take place at the Queen Elizabeth II Conference Centre in London.
